The Rheumatologist
COVID-19 NewsACR Convergence
  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed
  • Home
  • Conditions
    • Rheumatoid Arthritis
    • SLE (Lupus)
    • Crystal Arthritis
      • Gout Resource Center
    • Spondyloarthritis
    • Osteoarthritis
    • Soft Tissue Pain
    • Scleroderma
    • Vasculitis
    • Systemic Inflammatory Syndromes
    • Guidelines
  • Resource Centers
    • Axial Spondyloarthritis Resource Center
    • Gout Resource Center
    • Psoriatic Arthritis Resource Center
    • Rheumatoid Arthritis Resource Center
    • Systemic Lupus Erythematosus Resource Center
  • Drug Updates
    • Biologics & Biosimilars
    • DMARDs & Immunosuppressives
    • Topical Drugs
    • Analgesics
    • Safety
    • Pharma Co. News
  • Professional Topics
    • Ethics
    • Legal
    • Legislation & Advocacy
    • Career Development
      • Certification
      • Education & Training
    • Awards
    • Profiles
    • President’s Perspective
    • Rheuminations
    • Interprofessional Perspective
  • Practice Management
    • Billing/Coding
    • Quality Assurance/Improvement
    • Workforce
    • Facility
    • Patient Perspective
    • Electronic Health Records
    • Apps
    • Information Technology
    • From the College
    • Multimedia
      • Audio
      • Video
  • Resources
    • Issue Archives
    • ACR Convergence
      • Gout Resource Center
      • Axial Spondyloarthritis Resource Center
      • Psoriatic Arthritis
      • Abstracts
      • Meeting Reports
      • ACR Convergence Home
    • American College of Rheumatology
    • ACR ExamRheum
    • Research Reviews
    • ACR Journals
      • Arthritis & Rheumatology
      • Arthritis Care & Research
      • ACR Open Rheumatology
    • Rheumatology Image Library
    • Treatment Guidelines
    • Rheumatology Research Foundation
    • Events
  • About Us
    • Mission/Vision
    • Meet the Authors
    • Meet the Editors
    • Contribute to The Rheumatologist
    • Subscription
    • Contact
  • Advertise
  • Search
You are here: Home / Articles / Update on ACR’s Rheumatology-Specific APM

Update on ACR’s Rheumatology-Specific APM

January 5, 2018 • By Mary Beth Nierengarten

  • Tweet
  • Email
Print-Friendly Version / Save PDF

Efforts by the ACR to develop a rheumatology-specific alternative payment model (APM) are well under way. The first draft proposal was approved by the ACR Board of Directors in November and presented to the rheumatology community during the 2017 ACR/ARHP Annual Meeting in San Diego.

You Might Also Like
  • The ACR Is Exploring a Rheumatology-Specific APM
  • Quality Update Reporting Changes under MACRA
  • Value for Service: ACR Update on RUC & CPT Activities
Also By This Author
  • A New Administration Brings Updated ACR Policy Positions

The ACR is pursuing the development of a rheumatology-specific APM to offer rheumatologists a specialty-driven, value-based reimbursement option for Medicare patients enrolled in their practices. Under the Medicare Access and CHIP Reauthorization Act (MACRA) of 2015, physicians and practices can choose an APM as one of two avenues for reimbursement of Medicare patients. The other avenue is through the Merit-Based Incentive Payment System (MIPS).

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

A Focus on RA
The current APM is focused on the treatment of rheumatoid arthritis (RA), with emphasis on the importance of recognizing RA as a lifelong condition that requires different levels and types of treatment, depending on the stage of the disease. Such recognition is key to ensuring that reimbursement for these different levels and types of RA treatment is appropriate.

“The model was created to reduce burdens to good care, pay for high-value services and provide flexibility for various practice environments,” says Kwas Huston, MD, who works at the Center for Rheumatic Disease in Kansas City, Mo., and serves as co-chair of the ACR working group that is developing the APM.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

In addition, he says, providing rheumatologists with an APM also “provides a mechanism to avoid MIPS penalties and reduce documentation burdens, and gives physicians more control over their destiny in the era of value-based payments.”

How the Model Works & Why
The APM model breaks down rheumatology care into four distinct phases:

  1. Diagnosis and treatment planning for patients with potential RA;
  2. Support for primary care practices in evaluating joint symptoms;
  3. Initial treatment of patients with RA; and
  4. Continued care for RA.

In a letter submitted to the Centers for Medicare and Medicaid Services (CMS), the ACR emphasized the importance of aligning reimbursement of RA treatment to the different stages of the disease, saying, “The APM reflects the varied involvement of the rheumatologists during these distinct stages, splitting payment into an initial stage for diagnosis (including, for example, communication with primary care physicians), followed by ongoing care stratified by disease severity and recognizing other illnesses that complicate treatment.”

ad goes here:advert-3
ADVERTISEMENT
SCROLL TO CONTINUE

Additionally, Colin Edgerton, MD, FACP, RhMSUS, chair of the ACR’s Committee on Rheumatologic Care, testified at a Congressional hearing in November about the ACR’s APM and called on Congress to minimize the financial risks and practical barriers that practicing rheumatologists could face in order to qualify for MACRA’s APM track. His testimony starts at 2:35:08 of the video.

Pages: 1 2 | Single Page

Filed Under: Billing/Coding, Practice Management, Rheumatoid Arthritis Tagged With: reimbursement option for Medicare patients, Rheumatoid Arthritis (RA), rheumatology-specific APM

You Might Also Like:
  • The ACR Is Exploring a Rheumatology-Specific APM
  • Quality Update Reporting Changes under MACRA
  • Value for Service: ACR Update on RUC & CPT Activities
  • Protect Your Practice: Action Update From the ACR’s Insurance Subcommittee

Meeting Abstracts

Browse and search abstracts from the ACR Convergence and ACR/ARP Annual Meetings going back to 2012.

Visit the Abstracts site »

ACR Convergence

Don’t miss rheumatology’s premier scientific meeting for anyone involved in research or the delivery of rheumatologic care or services.

Visit the ACR Convergence site »

Rheumatology Research Foundation

The Foundation is the largest private funding source for rheumatology research and training in the U.S.

Learn more »

The Rheumatologist newsmagazine reports on issues and trends in the management and treatment of rheumatic diseases. The Rheumatologist reaches 11,500 rheumatologists, internists, orthopedic surgeons, nurse practitioners, physician assistants, nurses, and other healthcare professionals who practice, research, or teach in the field of rheumatology.

About Us / Contact Us / Advertise / Privacy Policy / Terms of Use / Cookie Preferences

  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed

Copyright © 2006–2023 American College of Rheumatology. All rights reserved.

ISSN 1931-3268 (print)
ISSN 1931-3209 (online)